Eliciting or boosting T cell recognition of cancer cells has led to major clinical breakthroughs. Immune checkpoint inhibitors, which consist of antibodies that block inhibitory receptors expressed on ...
The monomorphic antigen-presenting molecule CD1d presents lipid antigens to both αβ and γδ T cells. While type I natural killer T cells (NKT) display exquisite specificity for CD1d presenting ...
The research team engineered CD8+ Jurkat T cells to express SVAR16, a human TCR with intermediate-to-high 2D affinity for the SARS-CoV-2-derived epitope HLAA2:01–YLQ, using lentiviral transduction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results